In addition, we examined protein levels of several LPS141 tumor-promoting genes (i.e., RUNX1, c-MYC, FOSL2, RUNX2, and SNAI2) after ETC-168 treatment [29]. The gene discussed is SNAI2; the disease is neoplasm.